
TEX10: A Novel Drug Target and Potential Therapeutic Direction for Sleep Apnea Syndrome
Introduction Sleep apnea syndrome (SAS) is characterized by recurrent episodes of complete (apnea) or partial (hypopnea) upper airway obstruction during sleep, with each episode lasting ≥10 seconds and occurring ≥5 times per hour of sleep.1,2 Based on …